Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study

BACKGROUND: Glatiramer acetate (GA) and interferon-beta (INFb) are first-line disease modifying drugs for relapsing remitting multiple sclerosis (RRMS). Treatment with INFb is associated with a significant increase in health-related quality of life (HR-QoL) in the first 12 months. It is not known wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jongen, Peter J, Lehnick, Dirk, Sanders, Evert, Seeldrayers, Pierette, Fredrikson, Sten, Andersson, Magnus, Speck, Joachim
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2999586/
https://ncbi.nlm.nih.gov/pubmed/21078142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-8-133
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados